Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
-
Research
- Experts
In The News
View AllMedical Xpress features Dr. Alexia Torke
Alexia M. Torke, M.D., M.S., was featured by Medical Xpress...
Influence
View AllPredicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling
Published in the Alzheimer’s & Dementia: The Journal of the...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
February 22, 2023
Dr. Boustani in Clinical Research News

"*" indicates required fields